India launches a national plan to eliminate malaria

WHO/ Andrew Caballero-Reynolds

11 February 2016 – India’s Ministry of Health today launched an ambitious roadmap to eliminate malaria nationwide. The National Framework for Malaria Elimination in India 2016-2030, unveiled in New Delhi, aims to reduce malaria case incidence and deaths to zero over the next 15 years. According to the World Malaria Report 2015, there were an estimated 1.1 million confirmed cases of malaria in India in 2014. Despite a significant reduction in malaria case incidence since 2000, India accounts for approximately 70% of the regional malaria burden in South-East Asia.

Revised WHO manual on malaria microscopy quality assurance

WHO/ Nimal Garnage

3 February 2016 – Early and accurate laboratory confirmation of malaria with microscopy or rapid diagnostic tests is essential in endemic areas to improve the management of patients with febrile illnesses and to strengthen surveillance based on clinical malaria cases. The reliability of microscopy-based diagnosis of malaria depends on quality management systems in place and optimal use of resources. This manual is designed to assist managers of national malaria programmes and reference laboratories in investing in quality assurance of malaria microscopy. It will be released in French and Spanish soon.

WHO welcomes new initiative to combat insecticide resistance

Pierre Holtz /UNICEF

1 February 2016 – UNITAID and IVVC have announced a joint initiative to support African countries in obtaining new and effective insecticides at lower prices. Speaking at the launch event, Dr Pedro Alonso, Director of the WHO Global Malaria Programme, said: “Effective vector control is a cornerstone of our global strategy for malaria. We welcome this joint initiative to accelerate the development and deployment of new insecticides and vector control tools."

WHO issues its first position paper on a malaria vaccine

Mother and child in hospital, Kenya.

29 January 2016 – WHO issued today a position paper on RTS,S/AS01, a vaccine that provides partial protection against Plasmodium falciparum, the most deadly malaria parasite globally. RTS,S is the first malaria vaccine to complete pivotal Phase 3 testing and obtain a positive scientific opinion from a stringent medicines regulatory authority. The vaccine is being considered as a complementary malaria control tool in Africa that could potentially be added to – and not replace – the core package of proven malaria preventive, diagnostic and treatment interventions.

fact buffet


214 millionmalaria cases reported worldwide in 2015

Progress report


37%global decrease in malaria incidence between 2000 and 2015

Key facts


60%decrease in global malaria mortality rates between 2000 and 2015

Read more

Latest news

World Malaria Report 2015

This report contains the latest available data on malaria policies, interventions and trends in all endemic countries.

Global Technical Strategy for Malaria 2016-2030

The strategy aims to reduce global malaria incidence and mortality rates by 90% by 2030.

Contact us

Global Malaria Programme
World Health Organization
20 Avenue Appia
1211 Geneva 27
Tel: +41 22 791 2533
Fax: +41 22 791 4824